Research Objective Our goal is to develop new gene editing methods for producing universal, off-the-shelf, therapeutic T cells from induced pluripotent stem cells (iPSC) that can be applied to a… ...

Sphingosine phosphate lyase insufficiency syndrome (SPLIS) is a rare genetic condition caused by mutations in the SGPL1 gene. This gene encodes an essential enzyme needed to metabolize a group of ...

Meetings of the Grants Review Working Group will be held in a public session format except for the review of individual grant applications which will be conducted in closed session. THE ORDER OF ...

Les membres du public assistant à la réunion dans un lieu de téléconférence auront la possibilité de formuler des commentaires publics à chaque endroit, avec les mêmes limitations que celles imposées ...

El Instituto de Medicina Regenerativa de California y su Comité de Supervisión de Ciudadanos Independientes, y sus subcomités, cumplen con la Ley de Estadounidenses con Discapacidades (ADA, por sus ...

Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox.

Translating Center Dr. Amritha Jaishankar A Translating Center designed to expedite the development and delivery of high quality stem cell therapies to patients $15,000,000 Accelerating Center Peter ...

The mission of California Institute for Regenerative Medicine (CIRM) is to accelerate world class science to deliver transformative regenerative medicine treatments in an equitable manner to a diverse ...

Welcome to the frequently asked questions (FAQs) page of the California Institute for Regenerative Medicine (CIRM). Here, you’ll find answers to the most common questions you may have on CIRM. CIRM, ...

Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox.

Jonathan Thomas, PhD, JD, is President and CEO of the California Institute for Regenerative Medicine (CIRM). Thomas was previously the Chair of the CIRM governing Board from June 2011 to March 2023.

Through its strategic funding of clinical trials, CIRM helps advance innovative stem cell and gene therapy discoveries toward future treatments for patients. CIRM funds clinical trials across a broad ...